<?xml version="1.0"?>
<Articles JournalTitle="Journal of Pharmaceutical Care">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Pharmaceutical Care</JournalTitle>
      <Issn>2322-4630</Issn>
      <Volume>12</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Delivery of inhaled medication in children: Revisiting Pharmacological and Practical Issues for Better Health Outcome</title>
    <FirstPage>47</FirstPage>
    <LastPage>54</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Prashant</FirstName>
        <LastName>Mishra</LastName>
        <affiliation locale="en_US">Armed Forces Medical College Pune</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>02</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">For safe and effective therapy of respiratory disorders in children, delivering the medication at the site of disease i.e. directly into the respiratory tract via aerosolized medication is critical. But, the anatomical and physiological differences in the respiratory tract of infants/children and adults make the delivery of aerosolized medication complicated. This review article will give an overview of the delivery of inhaled medication in children and discuss the pharmacological and specific clinically relevant aspects of medication delivery using nebulizers, pressurized metered dose inhalers (MDIs), and dry powder inhalers (DPIs) in children.</abstract>
    <web_url>https://jpc.tums.ac.ir/index.php/jpc/article/view/636</web_url>
  </Article>
</Articles>
